These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1913177)

  • 41. [Selective lesions of serotonergic raphe neurons produced by 5,7-dihydroxytryptamine: effects on interspecific aggressive behavior in the rat].
    Vergnes M; Penot C; Kempf E; Mack G
    Brain Res; 1977 Sep; 133(1):167-71. PubMed ID: 561640
    [No Abstract]   [Full Text] [Related]  

  • 42. Specific neurotoxin lesions of median raphe serotonergic neurons disrupt maternal behavior in the lactating rat.
    Barofsky AL; Taylor J; Tizabi Y; Kumar R; Jones-Quartey K
    Endocrinology; 1983 Nov; 113(5):1884-93. PubMed ID: 6685026
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative autoradiography of the serotonin transporter to assess the distribution of serotonergic projections from the dorsal raphe nucleus.
    Hensler JG; Ferry RC; Labow DM; Kovachich GB; Frazer A
    Synapse; 1994 May; 17(1):1-15. PubMed ID: 8042142
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serotonergic lesions alter cocaine-induced locomotor behavior and stress-activation of the mesocorticolimbic dopamine system.
    Morrow BA; Roth RH
    Synapse; 1996 Jul; 23(3):174-81. PubMed ID: 8807745
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different actions for acute and chronic administration of mirtazapine on serotonergic transmission associated with raphe nuclei and their innervation cortical regions.
    Yamamura S; Abe M; Nakagawa M; Ochi S; Ueno S; Okada M
    Neuropharmacology; 2011 Mar; 60(4):550-60. PubMed ID: 21195096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of selective lesioning of serotonin-containing neurons on the TSH-inhibiting action of d-fenfluramine in male rats.
    Di Renzo GF; Quattrone A; Schettini G; Preziosi P
    Life Sci; 1979 Feb; 24(6):489-94. PubMed ID: 431332
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of midbrain raphe lesion or 5,7-dihydroxytryptamine treatment on the prolactin-releasing action of quipazine and D-fenfluramine in rats.
    Quattrone A; Schettini G; di Renzo G; Tedeschi G; Preziosi P
    Brain Res; 1979 Sep; 174(1):71-9. PubMed ID: 487124
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of serotonin in the control of cerebral activity: studies with intracerebral 5,7-dihydroxytryptamine.
    Vanderwolf CH; Leung LW; Baker GB; Stewart DJ
    Brain Res; 1989 Dec; 504(2):181-91. PubMed ID: 2598021
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transplantation of serotonergic neurons into the 5,7-DHT-lesioned rat olfactory bulb restores the parameters of kindling.
    Camu W; Marlier L; Lerner-Natoli M; Rondouin G; Privat A
    Brain Res; 1990 Jun; 518(1-2):23-30. PubMed ID: 2202489
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of concurrent manipulations of cholinergic and noradrenergic systems on neocortical EEG and spatial learning.
    Riekkinen P; Sirviö J; Valjakka A; Pitkänen A; Partanen J; Riekkinen P
    Behav Neural Biol; 1990 Sep; 54(2):204-10. PubMed ID: 2173544
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Near-total loss of 'learning' and 'memory' as a result of combined cholinergic and serotonergic blockade in the rat.
    Vanderwolf CH
    Behav Brain Res; 1987 Jan; 23(1):43-57. PubMed ID: 2950902
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of THA on scopolamine and nucleus basalis lesion-induced EEG slowing.
    Riekkinen P; Jäkälä P; Sirviö J; Koivisto E; Miettinen R; Riekkinen P
    Brain Res Bull; 1991 Apr; 26(4):633-7. PubMed ID: 1868362
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Animal models of human amnesia and dementia: hippocampal and amygdala ablation compared with serotonergic and cholinergic blockade in the rat.
    Dickson CT; Vanderwolf CH
    Behav Brain Res; 1990 Dec; 41(3):215-27. PubMed ID: 2288673
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-reversal of scopolamine- or age-related EEG changes by ondansetron, methysergide or alaproclate.
    Riekkinen P; Sirviö J; Riekkinen P
    Psychopharmacology (Berl); 1991; 103(4):567-70. PubMed ID: 1829538
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of cyclazocine and scopolamine on swim-to-platform performance in rats.
    Buckton G; Zibrowski EM; Vanderwolf CH
    Brain Res; 2001 Dec; 922(2):229-33. PubMed ID: 11743954
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Some general anesthetics reduce serotonergic neocortical activation and enhance the action of serotonergic antagonists.
    Dringenberg HC; Vanderwolf CH
    Brain Res Bull; 1995; 36(3):285-92. PubMed ID: 7697382
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Joint cholinergic-serotonergic control of neocortical and hippocampal electrical activity in relation to behavior: effects of scopolamine, ditran, trifluoperazine and amphetamine.
    Vanderwolf CH; Stewart DJ
    Physiol Behav; 1986; 38(1):57-65. PubMed ID: 3786502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impaired acquisition of temporal differentiation performance following lesions of the ascending 5-hydroxytryptaminergic pathways.
    Wogar MA; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 1992; 107(2-3):373-8. PubMed ID: 1377396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Age-related cognitive deficits in rats are associated with a combined loss of cholinergic and serotonergic functions.
    Richter-Levin G; Segal M
    Ann N Y Acad Sci; 1993 Sep; 695():254-7. PubMed ID: 8239292
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atropine, scopolamine and hippocampal lesion effects on alternation performance of rats.
    White SR
    Pharmacol Biochem Behav; 1974 May; 2(3):297-307. PubMed ID: 4837901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.